Home › Diffuse Large B-Cell Lymphoma › North Dakota › Fargo
Diffuse Large B-Cell Lymphoma clinical trials in Fargo, ND
4 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Fargo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RecruitingPhase 2
- Essentia Health Cancer Center-South University Clinic, Fargo
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RecruitingPhase 3
- Sanford Health Roger Maris Cancer Center ( Site 0189), Fargo
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 1003), Fargo
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RecruitingPhase 2
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Durham, NC14 studies
- Nashville, TN14 studies
- Dallas, TX13 studies
Other studies in Fargo
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Cancer (all types)11 studies
- Melanoma9 studies
- Obesity9 studies
- Prostate Cancer8 studies
- Overweight8 studies
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Pancreatic Cancer6 studies
- Colon Cancer6 studies
- Rectal Cancer6 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.